Resected tumor seeding in stomach wall due to endoscopic ultrasonography-guided fine needle aspiration of pancreatic adenocarcinoma

World J Gastroenterol. 2015 Jul 21;21(27):8458-61. doi: 10.3748/wjg.v21.i27.8458.

Abstract

Endoscopic ultrasonography-guided fine needle aspiration (EUS-FNA) is a useful and relatively safe tool for the diagnosis and staging of pancreatic cancer. However, there have recently been several reports of tumor seeding after EUS-FNA of adenocarcinomas. A 78-year-old man was admitted to our hospital due to upper gastric pain. Examinations revealed a 20 mm mass in the pancreatic body, for which EUS-FNA was performed. The cytology of the lesion was adenocarcinoma, and the stage of the cancer was T3N0M0. The patient underwent surgery with curative intent, followed by adjuvant chemotherapy with S-1. An enlarging gastric submucosal tumor was found on gastroscopy at 28 mo after surgery accompanied by a rising level of CA19-9. Biopsy result was adenocarcinoma, consistent with a pancreatic primary tumor. Tumor seeding after EUS-FNA was strongly suspected. The patient underwent surgical resection of the gastric tumor with curative intent. The pathological result of the resected gastric specimen was adenocarcinoma with a perfectly matched mucin special stain result with the previously resected pancreatic cancer. This is the first case report of tumor seeding after EUS-FNA which was surgically resected and inspected pathologically.

Keywords: Endoscopic ultrasonography-guided fine needle aspiration; Pancreatic cancer; Tumor seeding.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / secondary*
  • Adenocarcinoma / therapy
  • Aged
  • Antimetabolites, Antineoplastic / therapeutic use
  • Biopsy
  • Chemotherapy, Adjuvant
  • Drug Combinations
  • Endoscopic Ultrasound-Guided Fine Needle Aspiration / adverse effects*
  • Gastrectomy
  • Humans
  • Male
  • Neoplasm Seeding*
  • Neoplasm Staging
  • Oxonic Acid / therapeutic use
  • Pancreatectomy
  • Pancreatic Neoplasms / pathology*
  • Pancreatic Neoplasms / therapy
  • Stomach Neoplasms / secondary*
  • Stomach Neoplasms / surgery
  • Tegafur / therapeutic use
  • Time Factors
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Antimetabolites, Antineoplastic
  • Drug Combinations
  • S 1 (combination)
  • Tegafur
  • Oxonic Acid